Systemic Exposure to Fluticasone Propionate Administered via Metered-Dose Inhaler Containing Chlorofluorocarbon or Hydrofluoroalkane Propellant

被引:0
|
作者
Alison E. Mackie
Jo E. McDowall
Pietro Ventresca
Alan Bye
Christine Falcoz
Peter T. Daley-Yates
机构
[1] Lilly Research Centre,Clinical Pharmacology
[2] Glaxo Wellcome Research and Development,undefined
[3] Glaxo Wellcome Research and Development,undefined
来源
Clinical Pharmacokinetics | 2000年 / 39卷
关键词
Fluticasone Propionate; Absolute Bioavailability; Chlorofluorocarbon; Urinary Cortisol; Urinary Cortisol Excretion;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:17 / 22
页数:5
相关论文
共 42 条
  • [1] Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant
    Mackie, AE
    McDowall, JE
    Ventresca, P
    Bye, A
    Falcoz, C
    Daley-Yates, PT
    CLINICAL PHARMACOKINETICS, 2000, 39 (Suppl 1) : 17 - 22
  • [2] Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: performance and patient satisfaction
    Sheth, K.
    Wasserman, R. L.
    Lincourt, W. R.
    Locantore, N. W.
    Carranza-Rosenzweig, J.
    Crim, C.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (10) : 1218 - 1224
  • [3] Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate
    Lipworth, BJ
    Jackson, CM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (06) : 866 - 868
  • [4] Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness
    Langley, SJ
    Holden, J
    Derham, A
    Hedgeland, P
    Sharma, RK
    Woodcock, A
    CHEST, 2002, 122 (03) : 806 - 811
  • [5] Dose proportionality of fluticasone propionate from hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs
    Kunka, R
    Andrews, S
    Pimazzoni, M
    Callejas, S
    Ziviani, L
    Squassante, L
    Daley-Yates, PT
    RESPIRATORY MEDICINE, 2000, 94 : S10 - S16
  • [6] Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler
    Dempsey, OJ
    Wilson, AM
    Coutie, WJR
    Lipworth, BJ
    CHEST, 1999, 116 (04) : 935 - 940
  • [7] Absorption Kinetics after Inhalation of Fluticasone Propionate via the Diskhaler®, Diskus® and Metered-Dose Inhaler in Healthy Volunteers
    Charles Brindley
    Christine Falcoz
    Alison E. Mackie
    Alan Bye
    Clinical Pharmacokinetics, 2000, 39 : 1 - 8
  • [8] Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma
    Condemi, JJ
    Chervinsky, P
    Goldstein, MF
    Ford, LB
    Berger, WE
    Ayars, GH
    Rogenes, PR
    Edwards, L
    Pepsin, PJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (04) : 467 - 474
  • [9] Cost-effectiveness of fluticasone propionate administered via metered-dose inhaler plus BabyhalerTM spacer in the treatment of asthma in preschool-aged children
    Bisgaard, H
    Price, MJ
    Maden, C
    Olsen, NA
    CHEST, 2001, 120 (06) : 1835 - 1842
  • [10] Clinical Equivalence of a Salmeterol/Fluticasone Propionate Combination Product (50/500μg) Delivered via a Chlorofluorocarbon-Free Metered-Dose Inhaler with the Diskus™ in Patients with Moderate to Severe Asthma
    J. A. van Noord
    H. Lill
    T. Carrillo Diaz
    A. P. Greefhorst
    P. Davies
    Clinical Drug Investigation, 2001, 21 : 243 - 255